Daniel Venarske, MD
Allergy & Immunology · Jackson, MSNPI 1003892357
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $132,585 of the $155,691 with a category attached, or 85.2%. 36 manufacturers reported payments, led by GSK at 48.8% of the total. Among allergy & immunology clinicians in MS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 846 payments — averaging $184.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$76K
- AstraZeneca$61K
- Pfizer$4K
- Sanofi$3K
- Regeneron Healthcare Solutions, Inc.$3K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
- plus $7K from 30 others
What the payments were for
- Consulting fees$1980%
- Speaking & faculty fees$132,58585%
- Travel & lodging$4,0283%
- Food & beverage$18,56712%
- Education$3130%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 183 | $75,932 |
| AstraZeneca | 155 | $61,051 |
| Pfizer | 36 | $4,401 |
| Sanofi | 5 | $2,948 |
| Regeneron Healthcare Solutions, Inc. | 124 | $2,719 |
| Takeda Pharmaceuticals U.S.A., Inc. | 26 | $1,899 |
| CSL Behring | 62 | $1,669 |
| Novartis | 68 | $1,300 |
| Genentech USA, Inc. | 30 | $577 |
| Octapharma USA, Inc. | 25 | $502 |
| Amgen | 27 | $460 |
| Grifols USA, LLC | 23 | $424 |
| ADMA Biomanufacturing LLC | 4 | $344 |
| Kaleo, Inc. | 14 | $196 |
| Biocryst US Sales Co., LLC | 4 | $169 |
| AbbVie | 9 | $168 |
| LEO Pharma Inc. | 8 | $137 |
| Pharming Healthcare, Inc. | 7 | $125 |
| Incyte Corporation | 5 | $79 |
| Teva Pharmaceuticals USA, Inc. | 6 | $75 |
| Boehringer Ingelheim | 4 | $58 |
| Shire North American Group Inc | 3 | $55 |
| Argenx US, Inc. | 1 | $52 |
| Ionis Pharmaceuticals, Inc. | 2 | $50 |
| Genentech, Inc. | 1 | $50 |
| Arcutis Biotherapeutics, Inc. | 2 | $40 |
| Merck | 2 | $39 |
| QOL Medical, LLC | 2 | $38 |
| Blueprint Medicines Corporation | 1 | $32 |
| Mylan Specialty L.p. | 1 | $18 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $16 |
| Philips North America LLC | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
| Optinose US, Inc. | 1 | $14 |
| Organon | 1 | $13 |
| Cycle Pharmaceuticals Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$155,691 in reported general payments places this provider in the 90th percentile of 28 allergy & immunology providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 73 | $51,899 |
| Spiriva RespimatTiotropium Bromide | 15 | $17,172 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 17 | $16,989 |
| Breo ElliptaFluticasone/Vilanterol | 40 | $14,747 |
| Advair HfaFluticasone Propion/Salmeterol | 46 | $14,609 |
| SymbicortBudesonide/Formoterol Fumarate | 28 | $9,502 |
| DuleraMometasone/Formoterol | 18 | $6,219 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 33 | $4,986 |
| Azelastine Hcl | 146 | $4,498 |
| BreynaBudesonide/Formoterol Fumarate | 24 | $4,204 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 125 | $4,012 |
| Epinephrine | 18 | $3,606 |
| Fluticasone Propionate | 227 | $3,135 |
| Ipratropium Bromide | 55 | $1,821 |
| Montelukast Sodium | 255 | $1,415 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta | $75,932 | $66,647113 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $61,051 | $26,49145 claims |
| Boehringer IngelheimSpiriva Respimat | $58 | $17,17215 claims |
| MerckDulera | $39 | $6,21918 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 28 allergy & immunology providers in Mississippi.
Other allergy & immunology in Jackson
- Todd AdkinsJackson$226K
- Dexter WalcottJackson$154K
- Chelle WilhelmJackson$61K
- Joshua PhillipsJackson$20K
- Claire RosenblattJackson$11K
- James HaltomJackson$11K
- Gailen MarshallJackson$4K
- Sheryll VincentJackson$3K
- Matthew ElliottJackson$862
- Stephen KempJackson$68
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.